PHARMACIA AND UPJOHN FDA Approval NDA 019281

NDA 019281

PHARMACIA AND UPJOHN

FDA Drug Application

Application #019281

Documents

Letter1999-09-09
Letter2001-03-27
Letter2013-05-14
Label2013-05-14
Letter2008-12-24
Letter2009-01-30
Letter2011-02-02
Label2009-01-02
Label2011-01-31
Label2015-04-14
Review2001-06-18
Label2017-11-22
Letter2017-11-27
Label2020-06-08
Letter2020-06-08
Label2020-06-16
Letter2021-02-05
Label2021-02-08

Application Sponsors

NDA 019281PHARMACIA AND UPJOHN

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION100MG/ML1CYKLOKAPRONTRANEXAMIC ACID

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1986-12-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1994-11-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1996-12-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1996-07-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1996-07-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1994-11-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1996-07-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1996-07-24STANDARD
LABELING; LabelingSUPPL9AP1999-09-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1999-11-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP2000-04-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP2001-07-31STANDARD
LABELING; LabelingSUPPL13AP2001-03-27STANDARD
LABELING; LabelingSUPPL15AP2001-10-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP2001-11-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP2001-11-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2002-04-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2002-05-15STANDARD
LABELING; LabelingSUPPL25AP2008-12-22STANDARD
LABELING; LabelingSUPPL27AP2009-01-28STANDARD
LABELING; LabelingSUPPL30AP2011-01-25STANDARD
LABELING; LabelingSUPPL31AP2013-05-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL33AP2014-12-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL34AP2015-04-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL35AP2015-06-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL36AP2015-10-20STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL37AP2016-02-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL38AP2016-11-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL40AP2016-08-01STANDARD
LABELING; LabelingSUPPL41AP2017-11-21901 REQUIRED
LABELING; LabelingSUPPL44AP2020-06-07STANDARD
LABELING; LabelingSUPPL47AP2021-02-04STANDARD

Submissions Property Types

ORIG1Orphan5
SUPPL2Null14
SUPPL3Null14
SUPPL4Null14
SUPPL5Null14
SUPPL6Null14
SUPPL7Null14
SUPPL8Null14
SUPPL10Null14
SUPPL11Null14
SUPPL12Null14
SUPPL16Null14
SUPPL17Null14
SUPPL18Null14
SUPPL19Null14
SUPPL30Null6
SUPPL31Null6
SUPPL33Null14
SUPPL34Null14
SUPPL35Null14
SUPPL36Null14
SUPPL37Null14
SUPPL40Null14
SUPPL41Null7
SUPPL44Null15
SUPPL47Null7

TE Codes

001PrescriptionAP

CDER Filings

PFIZER
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19281
            [companyName] => PFIZER
            [docInserts] => ["",""]
            [products] => [{"drugName":"CYKLOKAPRON","activeIngredients":"TRANEXAMIC ACID","strength":"100MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"02\/04\/2021","submission":"SUPPL-47","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/019281Orig1s047lbl.pdf\"}]","notes":""},{"actionDate":"02\/04\/2021","submission":"SUPPL-47","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/019281Orig1s047lbl.pdf\"}]","notes":""},{"actionDate":"06\/07\/2020","submission":"SUPPL-44","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/019281s044lbl.pdf\"}]","notes":""},{"actionDate":"11\/21\/2017","submission":"SUPPL-41","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/019281s041lbl.pdf\"}]","notes":""},{"actionDate":"11\/21\/2017","submission":"SUPPL-41","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/019281s041lbl.pdf\"}]","notes":""},{"actionDate":"12\/15\/2014","submission":"SUPPL-33","supplementCategories":"Manufacturing (CMC)","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/019281s033lbl.pdf\"}]","notes":"This supplement type does not usually require new labeling."},{"actionDate":"05\/10\/2013","submission":"SUPPL-31","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/019281s031lbl.pdf\"}]","notes":""},{"actionDate":"01\/25\/2011","submission":"SUPPL-30","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/019281s030lbl.pdf\"}]","notes":""},{"actionDate":"12\/22\/2008","submission":"SUPPL-25","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/019281s025lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"CYKLOKAPRON","submission":"TRANEXAMIC ACID","actionType":"100MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2021-02-04
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.